GoldenGolden
Advanced Search
Johns Hopkins Medicine

Johns Hopkins Medicine

Johns Hopkins Medicine is a Baltimore-based healthcare company.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Helen K. Hughes
August 10, 2021
Harvard Business Review
Lessons from Johns Hopkins Medicine.
Science X staff
August 4, 2021
phys.org
Researchers from Johns Hopkins Medicine say they have added to evidence that a protein called CaMKII improves strength, endurance, muscle health and fitness in young animals. Their experiments working with mice and fruit flies, however, found that the gene for CaMKII also contributes to an evolutionary tradeoff: increased susceptibility to age-associated diseases, frailty and mortality.
July 7, 2021
WebWire
In what turned out to be one of the most important accidents of all time, Scottish bacteriologist Alexander Fleming returned to his laboratory after a vacation in 1928 to find a clear zone surrounding a piece of mold that had infiltrated a petri dish full of Staphylococcus aureus ( S. aureus ), a common skin bacterium he was growing. That region of no bacterial growth was the unplanned birth of a medical miracle, penicillin, and would lead to the era of antibiotics. Now, in a paper pub...
Jeevan Biswas
June 16, 2021
IBTimes India
According to a new study by researchers from Johns Hopkins Medicine, which is a follow-up to two earlier studies, three doses of COVID-19 may be required for the production of antibodies at levels ideal for fighting the SARS-CoV-2 coronavirus.
BioSpace
June 17, 2021
BioSpace
Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate therapies for multiple oncology indications, announced the formation of a new, urologic oncology focused Scientific Advisory Board.
June 15, 2021
ScienceDaily
In a new study, researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 -- the virus that causes COVID 19 -- more than the standard two-dose regimen for people who have received solid organ transplants.
Jeevan Biswas
May 9, 2021
IBTimes India
A study by researchers from Johns Hopkins Medicine has found that even after receiving the second dose of the COVID-19 vaccine, organ transplant recipients do not have sufficient antibodies to ease up on crucial safety measures such as the use of masks and physical distancing.
Alana Paterson and Julie Creswell
April 24, 2021
www.nytimes.com
Coffee for immune support. Supplements for inflammation. And psychedelics promising relief from serious ailments. Mushrooms are everywhere, and investors are paying attention.
Continental Who's Who
November 23, 2020
www.prnewswire.com:443
/PRNewswire/ -- Julie R. Brahmer, MD, MSc, is being recognized by Continental Who's Who as a Top Leading Oncologist for her outstanding contributions in the...
BioSpace
June 4, 2020
BioSpace
Dr. Majid Fotuhi, MD, PhD, a nationally-recognized neurologist, is warning about neurological issues in patients who suffer from COVID-19
April 20, 2020
WebWire
After a yearlong study of people with opioid dependence, Johns Hopkins Medicine researchers report evidence that adding $8 an hour to their paychecks may help those in recovery stay drug free longer, as well as encourage them to get and hold regular jobs. The researchers say poverty is an independent risk factor for drug abuse that treatment plans largely ignore. In a report on the study, described in the Journal of Epidemiology & Community Health online Feb. 21, the investigators s...
Stephanie Mlot
November 7, 2019
Geek.com
Apple is putting health records directly into veterans' pockets. The tech titan partnered with the U.S. Department of Veterans Affairs to give vets access to personal data on their iPhone. Following a trial ...
Benedict Carey
September 6, 2019
www.nytimes.com
The author of "The 4-Hour Workweek" is behind a surge in funding for clinical research into psychedelic drugs.
Benedict Carey
September 6, 2019
www.nytimes.com
The author of "The 4-Hour Workweek" is behind a surge in funding for clinical research into psychedelic drugs.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.